[CIS PIDD] [cis-pidd] Clinical protocol for PGM3 and other CDGs

[CIS-PIDD]

Dear Colleagues,

Our clinical protocol to provide supplemental GlcNAc and uridine to patients with PGM3 is now open (please see below).  The study is not limited to PGM3, rather any patient with a Congenital Disorder of Glycosylation (or evidence of abnormal glycosylation) with associated immunologic sequelae can be considered for enrollment.

https://clinicaltrials.gov/ct2/show/NCT02511041
http://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_2015-I-0159.html

Sincerely,
Jon
__________________________________________
Jonathan Lyons MD
Assistant Clinical Investigator
Genetics and Pathogenesis of Allergy Section
Laboratory of Allergic Diseases
NIAID/NIH

10 Center Drive
Bldg 10-CRC, Rm 5-3840 MSC 1889
Bethesda, MD 20892
phone: 301.443.5250
fax: 301.480.5757
email: jonathan.lyons at nih.gov<mailto:jonathan.lyons at nih.gov>

The information in this e-mail and any of its attachments is confidential and may contain sensitive information. It should not be used by anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete it from your mailbox or any other storage devices. National Institute of Allergy and Infectious Diseases shall not accept liability for any statements made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives.

---
You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://cts.dundee.net/u?id=96396833.5a9591ccd1e327fe6bc4d1543298c482&n=T&l=cis-pidd&o=3155406
or send a blank email to leave-3155406-96396833.5a9591ccd1e327fe6bc4d1543298c482 at lyris.dundee.net
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20150924/c8a25ba5/attachment-0001.html>